Sandoz Group AG | WebDisclosure

Basculer en Français

10020	Companies
203496	Keywords
133944	Articles
107981	Press releases

Home
Companies
Sandoz Group AG

PRESS RELEASE

published on 01/12/2026 at 15:00, 1 month 29 days ago

Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity
Sandoz CEO to outline plans for capturing the unprecedented 'golden decade' of affordable medicines opportunity at the 44th Annual J.P. Morgan Healthcare Conference

CEO Sandoz J.P. Morgan Healthcare Conference Golden Decade Affordable Medicines
BRIEF

published on 12/08/2025 at 07:05, 3 months 3 days ago

Sandoz Acquires Just-Evotec Biologics EU SAS to Boost Biosimilar Leadership

Acquisition Healthcare Biosimilars Sandoz Group AG Continuous Manufacturing
BRIEF

published on 12/08/2025 at 07:05, 3 months 3 days ago

Sandoz acquiert Just-Evotec Biologics EU SAS pour renforcer son leadership dans le domaine des biosimilaires

Acquisition Soins De Santé Biosimilaires Groupe Sandoz AG Fabrication Continue
PRESS RELEASE

published on 12/08/2025 at 07:00, 3 months 3 days ago

Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership
Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership. Expands capabilities for biosimilars with cutting-edge technology

Acquisition Biosimilars Sandoz Just-Evotec Biologics EU SAS Continuous-manufacturing Technology
BRIEF

published on 12/01/2025 at 07:05, 3 months 10 days ago

Sandoz lance des biosimilaires de dénosumab en Europe

Sandoz Wyost® Jubbonti® Biosimilaires Du Dénosumab Santé Osseuse
BRIEF

published on 12/01/2025 at 07:05, 3 months 10 days ago

Sandoz Launches Denosumab Biosimilars in Europe

Bone Health Sandoz Denosumab Biosimilars Wyost® Jubbonti®
PRESS RELEASE

published on 12/01/2025 at 07:00, 3 months 10 days ago

Sandoz launches denosumab biosimilars in Europe, providing affordable treatment option for cancer-related bone disease and osteoporosis for millions of patients
Sandoz launches denosumab biosimilars in Europe, providing affordable treatment options for cancer-related bone disease and osteoporosis. The European launch marks a key milestone in Sandoz's growth strategy

Europe Biosimilars Cancer Osteoporosis Sandoz
BRIEF

published on 11/24/2025 at 07:05, 3 months 17 days ago

Sandoz lance Afqlir® en Europe pour le traitement des maladies rétiniennes

Biosimilaires Maladies De La Rétine Sandoz Lancement En Europe Afqlir®
BRIEF

published on 11/24/2025 at 07:05, 3 months 17 days ago

Sandoz Launches Afqlir® in Europe for Retinal Diseases

Biosimilars Retinal Diseases Sandoz Europe Launch Afqlir®
PRESS RELEASE

published on 11/24/2025 at 07:00, 3 months 17 days ago

Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases
Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases. Afqlir® matches reference medicine in efficacy, safety, and pharmacokinetics, reinforcing Sandoz commitment to patient access

Retinal Diseases Sandoz Aflibercept Afqlir European Launch

Accesswire

Published on 03/11/2026 at 13:00, 28 minutes ago

GameSquare Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Published on 03/11/2026 at 12:30, 58 minutes ago

Algo Grande Identifies Additional Skarn Mineralization 3km South of Cerro Grande, With Samples Above 3% Copper and Confirms Copper in Multiple Targets on the Property
Published on 03/11/2026 at 12:30, 58 minutes ago

Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases
Published on 03/11/2026 at 12:23, 1 hour 5 minutes ago

SLAM Acquires New Copper Nickel Cobalt Showing Adjacent to Goodwin
Published on 03/11/2026 at 12:01, 1 hour 27 minutes ago

Northfield Capital Announces Planned Name Change to Juno International Corp.

View all ACCESSWIRE

EQS Group

Published on 03/11/2026 at 13:03, 25 minutes ago

NVIDIA and Nebius partner to scale full-stack AI cloud
Published on 03/11/2026 at 12:49, 39 minutes ago

Net Asset Value(s)
Published on 03/11/2026 at 12:30, 58 minutes ago

Wolftank Group successfully completes hydrogen infrastructure order for TPER – second refueling station in Bologna finalized
Published on 03/11/2026 at 12:25, 1 hour 3 minutes ago

MINISFORUM's N5 MAX Marks a Breakthrough in NAS Industry with Built-in OpenClaw in Local Computing
Published on 03/11/2026 at 12:05, 1 hour 23 minutes ago

Kasowitz LLP Publishes an Updated Report Examining the Fundamental Due Process Defects Underlying the Continued Detention and Prosecution of Erion Veliaj, the Mayor of Tirana, Albania

Les Echos

Published on 03/11/2026 at 12:07, 1 hour 20 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 3 mars 2026
Published on 03/11/2026 at 10:02, 3 hours 26 minutes ago

WEB SA - MODIFICATION AGENDA FINANCIER EXERCICE 2025
Published on 03/11/2026 at 08:00, 5 hours 28 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
Published on 03/11/2026 at 08:00, 5 hours 28 minutes ago

BIOPHYTIS ANNONCE LA REALISATION D’UNE LEVEE DE FONDS DE PLUS DE 2 MILLIONS D’EUROS ET LE REMBOURSEMENT DE L’INTEGRALITE DE SA DETTE CONVERTIBLE A PRIX VARIABLE
Published on 03/11/2026 at 07:00, 6 hours 28 minutes ago

TINC publishes excellent results with a record investment year as the basis for future profit growth

View all LES ECHOS COMFI WIRE